Table 5.
Antimicrobials | Pooled estimates of resistant isolates (Proportion) | |||||||
---|---|---|---|---|---|---|---|---|
E. coli | P. aeruginosa | K. pneumoniae | P. mirabilis | |||||
ES (95% CI) | I2 (%) | ES (95% CI) | I2 (%) | ES (95% CI) | I2 (%) | ES (95% CI) | I2 (%) | |
AMO | 0.73 (0.63, 0.83) | 55.70 | 0.87 (0.82, 0.92) | 0.00 | 0.90 (0.83, 0.97) | 43.97 | 0.75 (0.57, 0.93) | 86.81 |
AMC | 0.57 (0.44, 0.70) | 74.51 | 0.77 (0.63, 0.91) | 63.67 | 0.67 (0.51, 0.83) | 78.01 | 0.45 (0.36, 0.54) | 19.01 |
AMP | 0.84 (0.76, 0.91) | 75.08 | 0.95 (0.92, 0.99) | 0.00 | 0.88 (0.83, 0.93) | 24.27 | 0.78 (0.70, 0.85) | 39.67 |
CIP | 0.27 (0.16, 0.37) | 86.99 | 0.16 (0.09, 0.24) | 87.63 | 0.29 (0.15, 0.42) | 85.50 | 0.12 (0.06, 0.19) | 73.68 |
CRO | 0.45 (0.31, 0,60) | 89.81 | 0.58 (0.35, 0.82) | 95.86 | 0.57 (0.39, 0.75) | 92.32 | 0.43 (0.24, 0.63) | 94.04 |
SXT | 0.53 (0.43, 0.64) | 75.91 | 0.76 (0.68, 0.85) | 51.82 | 0.64 (0.51, 0.77) | 76.58 | 0.56 (0.39, 0.72) | 88.19 |
GEN | 0.24 (0.16, 0.33) | 93.09 | 0.18 (0.11, 0.26) | 66.47 | 0.37 (0.22, 0.52) | 89.66 | 0.21 (0.12, 0.30) | 74.31 |
AMO Amoxicillin, AMP Ampicillin, AMC Amoxicillin-clavulanic acid, SXT Cotrimoxazole, CRO Ceftriaxone, CIP Ciprofloxacin, GEN Gentamicin